Risk and protective factors for coronary atherosclerosis and myocardial dysfunction in individuals with long-duration type 1 diabetes
Open Access
- 20 August 2025
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 68 (11) , 2581-2594
Abstract
Aims/hypothesis CVD remains a major cause of mortality in people with long-duration type 1 diabetes, even among those without diabetic kidney disease (DKD). We assessed biomarkers that may be associated with CVD risks among the Joslin ‘Medalists’, namely those with type 1 diabetes of ≥50 years. Methods In this cross-sectional study, participants were evaluated for self-reported CVD (n=1038), with subsets undergoing coronary artery calcium (CAC; n=142) and cardiac magnetic resonance (CMR; n=111) imaging. Using multivariable regression analysis, multiple circulating factors such as inflammatory biomarkers and osteopontin (n=300) were analysed for associations with CVD, CAC and CMR, adjusting for DKD and other cardiometabolic and glycaemic risk factors, including HbA1c, continuous glucose monitor (n=102) metrics and advanced glycation end-products (n=200). Results Only 32% of participants had DKD (eGFR 2), but 40% had CVD. Despite having excellent cardiometabolic management (mean blood pressure of 132/64 mmHg; LDL and HDL-cholesterol of 2.10 mmol/l and 1.69 mmol/l, respectively, and a median HbA1c of 54.1 mmol/mol [7.1%]), participants exhibited a high CAC burden (median score 937), which did not differ between those with and without DKD (1136 vs 878, respectively). Among the glycaemic markers, HbA1c, but not hypoglycaemia or glycaemic variability, remained associated with CVD (OR 1.40, pp<0.01) in the non-DKD group compared with the DKD group. Conclusions/interpretation Ageing people with long-duration type 1 diabetes and without DKD, but with excellent cardiometabolic management, still possess a high burden of coronary atherosclerosis. Improving hyperglycaemia and mitigating inflammation, especially osteopontin, are potentially important for the management of CVD in long-duration type 1 diabetes. Graphical AbstractKeywords
Funding Information
- American Diabetes Association (ADA 9-18-CVD1-005)
- Thomas J. Beatson Foundation (Beatson 50-Year Medalist Fund, Beatson Pledge Fund)
- Iacocca Family Foundation
- National Heart, Lung, and Blood Institute (R01 HL155717, R01 HL161864-01)
- Dianne Nunnally Hoppes Fund
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK036836)
This publication has 40 references indexed in Scilit:
- The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reductionJournal of Clinical Lipidology, 2021
- The Association of Coronary Artery Calcification With Subsequent Incidence of Cardiovascular Disease in Type 1 DiabetesJACC: Cardiovascular Imaging, 2019
- The role of coronary artery calcification testing in incident coronary artery disease risk prediction in type 1 diabetesDiabetologia, 2018
- Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of AtherosclerosisJAMA Cardiology, 2017
- Recent trends in life expectancy for people with type 1 diabetes in SwedenDiabetologia, 2016
- Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparationAmino Acids, 2013
- COMPASS 31: A Refined and Abbreviated Composite Autonomic Symptom ScoreMayo Clinic Proceedings, 2012
- Progression of Coronary Artery Calcium in Type 1 Diabetes MellitusThe American Journal of Cardiology, 2007
- Fundus Photographic Risk Factors for Progression of Diabetic RetinopathyOphthalmology, 1991
- Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitusThe American Journal of Cardiology, 1987